LGND - Ligand Pharmaceuticals Chief Executive Officer Trades $237K In Company Stock | Benzinga
Todd C Davis, Chief Executive Officer at Ligand Pharmaceuticals (NASDAQ:LGND), reported a large insider buy on September 25, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Davis purchased 4,000 shares of Ligand Pharmaceuticals. The total transaction amounted to $237,528.
Ligand Pharmaceuticals shares are trading up 2.17% at $60.14 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, ...